1. Home
  2. KRRO vs OPRT Comparison

KRRO vs OPRT Comparison

Compare KRRO & OPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • OPRT
  • Stock Information
  • Founded
  • KRRO 2014
  • OPRT 2005
  • Country
  • KRRO United States
  • OPRT United States
  • Employees
  • KRRO N/A
  • OPRT N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • OPRT Finance: Consumer Services
  • Sector
  • KRRO Health Care
  • OPRT Finance
  • Exchange
  • KRRO Nasdaq
  • OPRT Nasdaq
  • Market Cap
  • KRRO 209.6M
  • OPRT 221.5M
  • IPO Year
  • KRRO 2019
  • OPRT 2019
  • Fundamental
  • Price
  • KRRO $17.41
  • OPRT $5.49
  • Analyst Decision
  • KRRO Strong Buy
  • OPRT Buy
  • Analyst Count
  • KRRO 7
  • OPRT 2
  • Target Price
  • KRRO $132.17
  • OPRT $8.00
  • AVG Volume (30 Days)
  • KRRO 92.3K
  • OPRT 548.6K
  • Earning Date
  • KRRO 03-18-2025
  • OPRT 05-08-2025
  • Dividend Yield
  • KRRO N/A
  • OPRT N/A
  • EPS Growth
  • KRRO N/A
  • OPRT N/A
  • EPS
  • KRRO N/A
  • OPRT N/A
  • Revenue
  • KRRO $2,271,000.00
  • OPRT $763,617,000.00
  • Revenue This Year
  • KRRO N/A
  • OPRT $28.45
  • Revenue Next Year
  • KRRO N/A
  • OPRT $9.19
  • P/E Ratio
  • KRRO N/A
  • OPRT N/A
  • Revenue Growth
  • KRRO N/A
  • OPRT N/A
  • 52 Week Low
  • KRRO $15.21
  • OPRT $2.05
  • 52 Week High
  • KRRO $98.00
  • OPRT $9.25
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 30.45
  • OPRT 43.63
  • Support Level
  • KRRO $16.78
  • OPRT $5.50
  • Resistance Level
  • KRRO $25.25
  • OPRT $6.11
  • Average True Range (ATR)
  • KRRO 2.92
  • OPRT 0.40
  • MACD
  • KRRO -0.25
  • OPRT -0.07
  • Stochastic Oscillator
  • KRRO 16.57
  • OPRT 18.59

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About OPRT Oportun Financial Corporation

Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.

Share on Social Networks: